RespireRx Pharmaceuticals Inc (OTCMKTS:RSPI) Stock Continues to Trend Lower: Down 13% In a Week

In the past few days, the RespireRx Pharmaceuticals Inc (OTCMKTS:RSPI) stock has been in a bit of doldrums as investors sold it off and the situation remained the same yesterday, as it ended the day with a decline of 7%.

Trading Data

On Tuesday, RSPI stock moved down 6.55% to $0.0136 with more than 380k shares traded, compared to its average volume of 366k shares. The stock has moved within a range of $0.0130 – 0.0140 after opening trading at $0.0140.

RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase™

That took the total decline of the stock over the course of the past week to as much as 11%. However, at the same time, it should be noted that despite the decline in the stock yesterday, the company did make a key announcement that investors could look into. First and foremost, it needs to be pointed out that RespireRx Pharmaceuticals is one of the leaders in the industry involved with the development and discovery of medicines meant for neurological and psychiatric conditions.

Yesterday, the company announced that Jeff Margolis, its Chief Financial Officer is going to be one of the presented at that Life Sciences Virtual Investor Conference. It is a key industry event and is going to be held on December 16, 2021 at 10 a.m. Eastern Standard Time. On the other hand, the Chief Executive Officer and President of RespireRx Tim Jones will be presenting by way of a pre-recorded address at the Biotech Showcase the day after.

Technical Data

RSPI stock is trading below the 20-Day and 50-Day Moving averages of $0.0161 and $0.0198 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0315. The stock is down 47% in the past month.